Abstract
Precise replication of genetic material and its equal distribution to daughter cells are essential to maintain genome stability. In eukaryotes, chromosome replication and segregation are temporally uncoupled, occurring in distinct intervals of the cell cycle, S and M phases, respectively. Cyclin E accumulates at the G1/S transition, where it promotes S phase entry and progression by binding to and activating CDK2. Several lines of evidence from different models indicate that cyclin E/CDK2 deregulation causes replication stress in S phase and chromosome segregation errors in M phase, leading to genomic instability and cancer. In this chapter, we will discuss the main findings that link cyclin E/CDK2 deregulation to genomic instability and the molecular mechanisms by which cyclin E/CDK2 induces replication stress and chromosome aberrations during carcinogenesis.
This is a preview of subscription content, log in via an institution to check access.
References
Accordi B, Espina V, Giordan M, VanMeter A, Milani G, Galla L, Ruzzene M, Sciro M, Trentin L, De Maria R, te Kronnie G, Petricoin E, Liotta L, Basso G (2010) Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL. PLoS One 5(10):e13552. https://doi.org/10.1371/journal.pone.0013552
Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommun B, Trouche D, Harel-Bellan A (1998) Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396(6707):184–186. https://doi.org/10.1038/24190
Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K (2007) Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res 67(15):7212–7222. https://doi.org/10.1158/0008-5472.can-07-0599
Bagheri-Yarmand R, Nanos-Webb A, Biernacka A, Bui T, Keyomarsi K (2010) Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C. Cancer Res 70(12):5085–5095. https://doi.org/10.1158/0008-5472.can-09-4095
Bailey ML, Singh T, Mero P, Moffat J, Hieter P (2015) Dependence of human colorectal cells lacking the FBW7 tumor suppressor on the spindle assembly checkpoint. Genetics 201(3):885–895. https://doi.org/10.1534/genetics.115.180653
Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434(7035):864–870. https://doi.org/10.1038/nature03482
Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444(7119):633–637. https://doi.org/10.1038/nature05268
Bermejo R, Lai MS, Foiani M (2012) Preventing replication stress to maintain genome stability: resolving conflicts between replication and transcription. Mol Cell 45(6):710–718. https://doi.org/10.1016/j.molcel.2012.03.001
Berti M, Vindigni A (2016) Replication stress: getting back on track. Nat Struct Mol Biol 23(2):103–109. https://doi.org/10.1038/nsmb.3163
Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145(3):435–446. https://doi.org/10.1016/j.cell.2011.03.044
Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR (2010) Signatures of mutation and selection in the cancer genome. Nature 463(7283):893–898. https://doi.org/10.1038/nature08768
Blake MC, Azizkhan JC (1989) Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol 9(11):4994–5002
Bortner DM, Rosenberg MP (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17(1):453–459
Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM, Gronroos E, Chew SK, Rowan AJ, Schenk A, Sheffer M, Howell M, Kschischo M, Behrens A, Helleday T, Bartek J, Tomlinson IP, Swanton C (2013) Replication stress links structural and numerical cancer chromosomal instability. Nature 494(7438):492–496. https://doi.org/10.1038/nature11935
Burrow AA, Williams LE, Pierce LC, Wang YH (2009) Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics 10:59. https://doi.org/10.1186/1471-2164-10-59
Caldon CE, Musgrove EA (2010) Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 5:2. https://doi.org/10.1186/1747-1028-5-2
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65(6):1053–1061
Chen Z, Indjeian VB, McManus M, Wang L, Dynlacht BD (2002) CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3(3):339–350
Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM (1996) Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10(16):1979–1990
Costantino L, Sotiriou SK, Rantala JK, Magin S, Mladenov E, Helleday T, Haber JE, Iliakis G, Kallioniemi OP, Halazonetis TD (2014) Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343(6166):88–91. https://doi.org/10.1126/science.1243211
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale AL, Brenton JD, Tavare S, Caldas C, Aparicio S (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346–352. https://doi.org/10.1038/nature10983
Davis RJ, Welcker M, Clurman BE (2014) Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. Cancer Cell 26(4):455–464. https://doi.org/10.1016/j.ccell.2014.09.013
Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d’Adda di Fagagna F (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444(7119):638–642. https://doi.org/10.1038/nature05327
Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R (2007) Non-transcriptional control of DNA replication by c-Myc. Nature 448(7152):445–451. https://doi.org/10.1038/nature05953
Dou QP, Zhao S, Levin AH, Wang J, Helin K, Pardee AB (1994) G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem 269(2):1306–1313
Dulic V, Lees E, Reed SI (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257(5078):1958–1961
Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12(15):2245–2262
Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI (2004) Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 165(6):789–800. https://doi.org/10.1083/jcb.200404092
Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92(3):770–777
Fechter A, Buettel I, Kuehnel E, Savelyeva L, Schwab M (2007) Common fragile site FRA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions. Genes Chromosom Cancer 46(1):98–106. https://doi.org/10.1002/gcc.20389
Fisk HA, Winey M (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106(1):95–104
Fukuse T, Hirata T, Naiki H, Hitomi S, Wada H (2000) Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Res 60(2):242–244
Ge XQ, Jackson DA, Blow JJ (2007) Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev 21(24):3331–3341. https://doi.org/10.1101/gad.457807
Geisen C, Karsunky H, Yucel R, Moroy T (2003) Loss of p27Kip1 cooperates with cyclin E in T-cell lymphomagenesis. Oncogene 22(11):1724–1729. https://doi.org/10.1038/sj.onc.1206340
Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12(6):1173–1180
Godinho SA, Pellman D (2014) Causes and consequences of centrosome abnormalities in cancer. Philos Trans R Soc Lond B Biol Sci 369(1650):20130467. https://doi.org/10.1098/rstb.2013.0467
Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434(7035):907–913. https://doi.org/10.1038/nature03485
Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP (2005) Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437(7055):147–153. https://doi.org/10.1038/nature03915
Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6(7):493–505. https://doi.org/10.1038/nrc1885
Gu Y, Turck CW, Morgan DO (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366(6456):707–710. https://doi.org/10.1038/366707a0
Gudas JM, Payton M, Thukral S, Chen E, Bass M, Robinson MO, Coats S (1999) Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol 19(1):612–622
Guo SS, Arora C, Shimoide AT, Sawicki MP (2002) Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors. Mol Cell Endocrinol 190(1–2):109–114
Hanashiro K, Kanai M, Geng Y, Sicinski P, Fukasawa K (2008) Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells. Oncogene 27(40):5288–5302. https://doi.org/10.1038/onc.2008.161
Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14(19):2393–2409
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4):805–816
Helmrich A, Ballarino M, Tora L (2011) Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell 44(6):966–977. https://doi.org/10.1016/j.molcel.2011.10.013
Helmrich A, Ballarino M, Nudler E, Tora L (2013) Transcription-replication encounters, consequences and genomic instability. Nat Struct Mol Biol 20(4):412–418. https://doi.org/10.1038/nsmb.2543
Hills SA, Diffley JF (2014) DNA replication and oncogene-induced replicative stress. Curr Biol 24(10):R435–R444. https://doi.org/10.1016/j.cub.2014.04.012
Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283(5403):851–854
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70(6):993–1006
Hochegger H, Takeda S, Hunt T (2008) Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat Rev Mol Cell Biol 9(11):910–916. https://doi.org/10.1038/nrm2510
Hosseini SA, Horton S, Saldivar JC, Miuma S, Stampfer MR, Heerema NA, Huebner K (2013) Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability. Genes Chromosom Cancer 52(11):1017–1029. https://doi.org/10.1002/gcc.22097
Hughes BT, Sidorova J, Swanger J, Monnat RJ Jr, Clurman BE (2013) Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation. Proc Natl Acad Sci U S A 110(22):8954–8959. https://doi.org/10.1073/pnas.1302927110
Hwang HC, Clurman BE (2005) Cyclin E in normal and neoplastic cell cycles. Oncogene 24(17):2776–2786. https://doi.org/10.1038/sj.onc.1208613
Hydbring P, Bahram F, Su Y, Tronnersjo S, Hogstrand K, von der Lehr N, Sharifi HR, Lilischkis R, Hein N, Wu S, Vervoorts J, Henriksson M, Grandien A, Luscher B, Larsson LG (2010) Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci U S A 107(1):58–63. https://doi.org/10.1073/pnas.0900121106
Ibarra A, Schwob E, Mendez J (2008) Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc Natl Acad Sci U S A 105(26):8956–8961. https://doi.org/10.1073/pnas.0803978105
Iida H, Towatari M, Tanimoto M, Morishita Y, Kodera Y, Saito H (1997) Overexpression of cyclin E in acute myelogenous leukemia. Blood 90(9):3707–3713
Jones RM, Mortusewicz O, Afzal I, Lorvellec M, Garcia P, Helleday T, Petermann E (2013) Increased replication initiation and conflicts with transcription underlie cyclin E-induced replication stress. Oncogene 32(32):3744–3753. https://doi.org/10.1038/onc.2012.387
Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Moroy T (1999) Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc. Oncogene 18(54):7816–7824. https://doi.org/10.1038/sj.onc.1203205
Kawabata T, Luebben SW, Yamaguchi S, Ilves I, Matise I, Buske T, Botchan MR, Shima N (2011) Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol Cell 41(5):543–553. https://doi.org/10.1016/j.molcel.2011.02.006
Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, Fukasawa K (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64(14):4800–4809. https://doi.org/10.1158/0008-5472.can-03-3908
Keck JM, Summers MK, Tedesco D, Ekholm-Reed S, Chuang LC, Jackson PK, Reed SI (2007) Cyclin E overexpression impairs progression through mitosis by inhibiting APCCdh1. J Cell Biol 178(3):371–385. https://doi.org/10.1083/jcb.200703202
Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS (2002) Cyclin E and survival in patients with breast cancer. N Engl J Med 347(20):1566–1575. https://doi.org/10.1056/NEJMoa021153
Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ (2001) Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294(5540):173–177. https://doi.org/10.1126/science.1065203
Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM (1991) Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66(6):1217–1228
Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM (1992) Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257(5077):1689–1694
Koundrioukoff S, Carignon S, Techer H, Letessier A, Brison O, Debatisse M (2013) Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity. PLoS Genet 9(7):e1003643. https://doi.org/10.1371/journal.pgen.1003643
Kumagai A, Shevchenko A, Shevchenko A, Dunphy WG (2011) Direct regulation of Treslin by cyclin-dependent kinase is essential for the onset of DNA replication. J Cell Biol 193(6):995–1007. https://doi.org/10.1083/jcb.201102003
Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci U S A 96(6):2817–2822
Lane AN, Fan TW (2015) Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res 43(4):2466–2485. https://doi.org/10.1093/nar/gkv047
Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W, Slingerland JM, Amati B (1998) Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 17(20):2637–2643. https://doi.org/10.1038/sj.onc.1202477
Le Tallec B, Dutrillaux B, Lachages AM, Millot GA, Brison O, Debatisse M (2011) Molecular profiling of common fragile sites in human fibroblasts. Nat Struct Mol Biol 18(12):1421–1423. https://doi.org/10.1038/nsmb.2155
Le Tallec B, Millot GA, Blin ME, Brison O, Dutrillaux B, Debatisse M (2013) Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes. Cell Rep 4(3):420–428. https://doi.org/10.1016/j.celrep.2013.07.003
Le Tallec B, Koundrioukoff S, Wilhelm T, Letessier A, Brison O, Debatisse M (2014) Updating the mechanisms of common fragile site instability: how to reconcile the different views? Cell Mol Life Sci 71(23):4489–4494. https://doi.org/10.1007/s00018-014-1720-2
Lee EB, Park TI, Park SH, Park JY (2003) Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer. Ann Thorac Surg 75(5):1597–1600
Letessier A, Millot GA, Koundrioukoff S, Lachages AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M (2011) Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470(7332):120–123. https://doi.org/10.1038/nature09745
Lew DJ, Dulic V, Reed SI (1991) Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66(6):1197–1206
Liberal V, Martinsson-Ahlzen HS, Liberal J, Spruck CH, Widschwendter M, McGowan CH, Reed SI (2012) Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins. Proc Natl Acad Sci U S A 109(8):2754–2759. https://doi.org/10.1073/pnas.1102434108
Liu E, Li X, Yan F, Zhao Q, Wu X (2004) Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation. J Biol Chem 279(17):17283–17288. https://doi.org/10.1074/jbc.C300549200
Loeb KR, Kostner H, Firpo E, Norwood T, D Tsuchiya K, Clurman BE, Roberts JM (2005) A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8(1):35–47. https://doi.org/10.1016/j.ccr.2005.06.010
Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, Wang J, Qin J, Chow LT, Harper JW (2000) Cell cycle-regulated phosphorylation of p220NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev 14(18):2298–2313
Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, Robbins DJ, Bentley HA, Tsongalis GJ, Demidenko E, Freemantle SJ, Dmitrovsky E (2007) Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A 104(10):4089–4094. https://doi.org/10.1073/pnas.0606537104
Macheret M, Halazonetis TD (2015) DNA replication stress as a hallmark of cancer. Annu Rev Pathol 10:425–448. https://doi.org/10.1146/annurev-pathol-012414-040424
Mailand N, Diffley JF (2005) CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 122(6):915–926. https://doi.org/10.1016/j.cell.2005.08.013
Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9(3):153–166. https://doi.org/10.1038/nrc2602
Matsumoto Y, Maller JL (2004) A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 306(5697):885–888. https://doi.org/10.1126/science.1103544
Matsumoto Y, Hayashi K, Nishida E (1999) Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9(8):429–432
Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430(6996):226–231. https://doi.org/10.1038/nature02650
Maya-Mendoza A, Ostrakova J, Kosar M, Hall A, Duskova P, Mistrik M, Merchut-Maya JM, Hodny Z, Bartkova J, Christensen C, Bartek J (2015) Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol Oncol 9(3):601–616. https://doi.org/10.1016/j.molonc.2014.11.001
McIntosh D, Blow JJ (2012) Dormant origins, the licensing checkpoint, and the response to replicative stresses. Cold Spring Harb Perspect Biol 4(10):012955. https://doi.org/10.1101/cshperspect.a012955
Meraldi P, Lukas J, Fry AM, Bartek J, Nigg EA (1999) Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat Cell Biol 1(2):88–93. https://doi.org/10.1038/10054
Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE (2002) p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 12(21):1817–1827
Minella AC, Grim JE, Welcker M, Clurman BE (2007) p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26(48):6948–6953. https://doi.org/10.1038/sj.onc.1210518
Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, Roberts JM, Clurman BE (2008) Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 22(12):1677–1689. https://doi.org/10.1101/gad.1650208
Miron K, Golan-Lev T, Dvir R, Ben-David E, Kerem B (2015) Oncogenes create a unique landscape of fragile sites. Nat Commun 6:7094. https://doi.org/10.1038/ncomms8094
Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK (2001) Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413(6853):311–316. https://doi.org/10.1038/35095068
Mohebi S, Mizuno K, Watson A, Carr AM, Murray JM (2015) Checkpoints are blind to replication restart and recombination intermediates that result in gross chromosomal rearrangements. Nat Commun 6:6357. https://doi.org/10.1038/ncomms7357
Morris L, Allen KE, La Thangue NB (2000) Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Nat Cell Biol 2(4):232–239. https://doi.org/10.1038/35008660
Muller-Tidow C, Metzger R, Kugler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B, Schneider PM, Koeffler HP, Berdel WE, Serve H (2001) Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 61(2):647–653
Muntean AG, Hess JL (2012) The pathogenesis of mixed-lineage leukemia. Annu Rev Pathol 7:283–301. https://doi.org/10.1146/annurev-pathol-011811-132434
Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA, Fukasawa K (2000) Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19(13):1635–1646. https://doi.org/10.1038/sj.onc.1203460
Neelsen KJ, Lopes M (2015) Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat Rev Mol Cell Biol 16(4):207–220. https://doi.org/10.1038/nrm3935
Neelsen KJ, Zanini IM, Herrador R, Lopes M (2013) Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates. J Cell Biol 200(6):699–708. https://doi.org/10.1083/jcb.201212058
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjaerde OC, Langerod A, Ringner M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O’Meara S, Pauporte I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodriguez-Gonzalez FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, van’t Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg A, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Borresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR (2016) Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534(7605):47–54. https://doi.org/10.1038/nature17676
Ohtani K, DeGregori J, Nevins JR (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A 92(26):12146–12150
Ohtani K, DeGregori J, Leone G, Herendeen DR, Kelly TJ, Nevins JR (1996) Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol Cell Biol 16(12):6977–6984
Ohtani K, Tsujimoto A, Ikeda M, Nakamura M (1998) Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene 17(14):1777–1785. https://doi.org/10.1038/sj.onc.1202105
Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, Nojima H (1999) Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18(14):2299–2309. https://doi.org/10.1038/sj.onc.1202544
Ohtsubo M, Roberts JM (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259(5103):1908–1912
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K (2000) Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103(1):127–140
Oswald F, Dobner T, Lipp M (1996) The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol Cell Biol 16(5):1889–1895
Ozeri-Galai E, Lebofsky R, Rahat A, Bester AC, Bensimon A, Kerem B (2011) Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. Mol Cell 43(1):122–131. https://doi.org/10.1016/j.molcel.2011.05.019
Ozeri-Galai E, Tur-Sinai M, Bester AC, Kerem B (2014) Interplay between genetic and epigenetic factors governs common fragile site instability in cancer. Cell Mol Life Sci 71(23):4495–4506. https://doi.org/10.1007/s00018-014-1719-8
Pearson BE, Nasheuer HP, Wang TS (1991) Human DNA polymerase α gene: sequences controlling expression in cycling and serum-stimulated cells. Mol Cell Biol 11(4):2081–2095
Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78(1):59–66
Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3(2):222–225
Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C (2004) Inactivation of hCDC4 can cause chromosomal instability. Nature 428(6978):77–81. https://doi.org/10.1038/nature02313
Resnitzky D, Gossen M, Bujard H, Reed SI (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14(3):1669–1679
Reynaud EG, Pelpel K, Guillier M, Leibovitch MP, Leibovitch SA (1999) p57Kip2 stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol Cell Biol 19(11):7621–7629
Rohban S, Campaner S (2015) Myc induced replicative stress response: how to cope with it and exploit it. Biochim Biophys Acta 1849(5):517–524. https://doi.org/10.1016/j.bbagrm.2014.04.008
Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM (1999) BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol 19(7):4843–4854
Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, Sauter G (2003) Cyclin E overexpression and amplification in human tumours. J Pathol 200(3):375–382. https://doi.org/10.1002/path.1356
Schwaenen C, Viardot A, Berger H, Barth TF, Bentink S, Dohner H, Enz M, Feller AC, Hansmann ML, Hummel M, Kestler HA, Klapper W, Kreuz M, Lenze D, Loeffler M, Moller P, Muller-Hermelink HK, Ott G, Rosolowski M, Rosenwald A, Ruf S, Siebert R, Spang R, Stein H, Truemper L, Lichter P, Bentz M, Wessendorf S (2009) Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosom Cancer 48(1):39–54. https://doi.org/10.1002/gcc.20617
Scuderi R, Palucka KA, Pokrovskaja K, Bjorkholm M, Wiman KG, Pisa P (1996) Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood 87(8):3360–3367
Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ, Hartford SA, Tye BK, Schimenti JC (2007) A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet 39(1):93–98. https://doi.org/10.1038/ng1936
Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V, Kluin-Nelemans HC, Giphart-Gassler M (2003) Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene 22(4):538–547. https://doi.org/10.1038/sj.onc.1206141
Siu KT, Rosner MR, Minella AC (2012) An integrated view of cyclin E function and regulation. Cell Cycle (Georgetown, Tex) 11(1):57–64. https://doi.org/10.4161/cc.11.1.18775
Siu KT, Xu Y, Swartz KL, Bhattacharyya M, Gurbuxani S, Hua Y, Minella AC (2014) Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation. Mol Cell Biol 34(17):3244–3258. https://doi.org/10.1128/mcb.01528-13
Smith AP, Henze M, Lee JA, Osborn KG, Keck JM, Tedesco D, Bortner DM, Rosenberg MP, Reed SI (2006) Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland. Oncogene 25(55):7245–7259. https://doi.org/10.1038/sj.onc.1209713
Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401(6750):297–300. https://doi.org/10.1038/45836
Srinivasan SV, Dominguez-Sola D, Wang LC, Hyrien O, Gautier J (2013) Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep 3(5):1629–1639. https://doi.org/10.1016/j.celrep.2013.04.002
Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413(6853):316–322. https://doi.org/10.1038/35095076
Teixeira LK, Wang X, Li Y, Ekholm-Reed S, Wu X, Wang P, Reed SI (2015) Cyclin E deregulation promotes loss of specific genomic regions. Curr Biol 25(10):1327–1333. https://doi.org/10.1016/j.cub.2015.03.022
Thean LF, Loi C, Ho KS, Koh PK, Eu KW, Cheah PY (2010) Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients. Genes Chromosom Cancer 49(2):99–106. https://doi.org/10.1002/gcc.20724
Thys RG, Lehman CE, Pierce LC, Wang YH (2015) DNA secondary structure at chromosomal fragile sites in human disease. Curr Genomics 16(1):60–70. https://doi.org/10.2174/1389202916666150114223205
Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K (2001) Specific phosphorylation of nucleophosmin on Thr199 by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276(24):21529–21537. https://doi.org/10.1074/jbc.M100014200
Torres-Rosell J, De Piccoli G, Cordon-Preciado V, Farmer S, Jarmuz A, Machin F, Pasero P, Lisby M, Haber JE, Aragon L (2007) Anaphase onset before complete DNA replication with intact checkpoint responses. Science 315(5817):1411–1415. https://doi.org/10.1126/science.1134025
Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78(1):67–74
Varetti G, Pellman D, Gordon DJ (2014) Aurea mediocritas: the importance of a balanced genome. Cold Spring Harb Perspect Biol 6(11):a015842. https://doi.org/10.1101/cshperspect.a015842
Weddington N, Stuy A, Hiratani I, Ryba T, Yokochi T, Gilbert DM (2008) Replication domain: a visualization tool and comparative database for genome-wide replication timing data. BMC Bioinformatics 9:530. https://doi.org/10.1186/1471-2105-9-530
Won KA, Reed SI (1996) Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 15(16):4182–4193
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366(6456):701–704. https://doi.org/10.1038/366701a0
Yamada H, Yanagisawa K, Tokumaru S, Taguchi A, Nimura Y, Osada H, Nagino M, Takahashi T (2008) Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosom Cancer 47(9):810–818. https://doi.org/10.1002/gcc.20582
Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS (1998) Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A 95(7):3603–3608
Yoshida K, Inoue I (2004) Regulation of geminin and Cdt1 expression by E2F transcription factors. Oncogene 23(21):3802–3812. https://doi.org/10.1038/sj.onc.1207488
Zariwala M, Liu J, Xiong Y (1998) Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 17(21):2787–2798. https://doi.org/10.1038/sj.onc.1202505
Zeman MK, Cimprich KA (2014) Causes and consequences of replication stress. Nat Cell Biol 16(1):2–9. https://doi.org/10.1038/ncb2897
Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, Harlow E (2000) NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev 14(18):2283–2297
Zhao H, Chen X, Gurian-West M, Roberts JM (2012) Loss of cyclin-dependent kinase 2 (CDK2) inhibitory phosphorylation in a CDK2AF knock-in mouse causes misregulation of DNA replication and centrosome duplication. Mol Cell Biol 32(8):1421–1432. https://doi.org/10.1128/mcb.06721-11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Teixeira, L.K., Reed, S.I. (2017). Cyclin E Deregulation and Genomic Instability. In: Masai, H., Foiani, M. (eds) DNA Replication. Advances in Experimental Medicine and Biology, vol 1042. Springer, Singapore. https://doi.org/10.1007/978-981-10-6955-0_22
Download citation
DOI: https://doi.org/10.1007/978-981-10-6955-0_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6954-3
Online ISBN: 978-981-10-6955-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)